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The only curative treatment for proximal bile duct cancer with involvement of both main hepatic ducts is
liver transplantation. Most patients do not fulfill the requirements for liver transplantation. Our
treatment strategy in appropriate cases is palliative tumor resection and reconstruction of the biliary
passage by sutureless bilioenteric anastomosis. We have treated 12 patients, 5 in combination with
intraluminal and percutaneous radiotherapy. Our results indicate that this strategy leads to effective
palliation in some cases provided that only microscopic residual tumor is left in-situ. Our survival times
compare favourably with survival after liver transplantation.
KEY WORDS" Proximal bile duct cancer, palliation, intrahepatic sutureless bilioenteric anastomosis,
intraluminal radiotherapy
INTRODUCTION
Bile duct cancer is a rare tumor accounting for 7% of all gastrointestinal
malignancies1. According to its location it can be subdivided into distal,
intermediate and proximal tumors2. This classification is essential as treatment
policy depends on tumor location.
In the past proximal bile duct tumors were classified into three types, according
to their extension in relation to the hepatic confluence 3. Type I are tumors of the
proximal main hepatic duct, which have not reached the hepatic confluence.
Tumors of the hepatic duct which have involved the hepatic confluence belong to
type II. Type III is present if there is evidence of invasion of at least one main
hepatic duct up to the branching of second order bile ducts. Due to therapeutic
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Figure Classification of proximal bile duct cancer Bismuth 19884.
considerations it is deemed useful to add a fourth type of proximal bile duct tumor
which is characterized by invasion of both main hepatic ducts
4 (Figure 1).
A prerequsite for potentially curative resection of proximal bile duct cancer is
that major structures of the porta hepatis like the portal vein and the hepatic artery
are, either, not invaded by the tumor or that their continuity can be reconstructed
after partial resection5’6. If this criterium is fulfilled, potentially curative resection is
possible with a safety margin of at least 1 cm. In case of type I and II tumors
curative treatment is based on local resection of the tumor combined with a radical
lymphadenectomy in the hepatoduodenal ligament6. In our opinion, type I and IIPALLIATION OF PROXIMAL BILE DUCT CANCER 237
tumors should be summarized in one category as the necessity of a safety margin of
1 cm will result in the same therapeutic regimen namely the resection of the hepatic
confluence. The biliary passage is reconstructed by two or three hepaticojejunal
anastomoses draining in one Roux-en-Y-loop of jejunum. If the tumor invades the
second order bile duct branches of one side of the liver, resectional treatment with
curative intention is possible by local resection of the tumor combined with a
hemihepatectomy of the affected lobe and a lymphadenectomy. In order to achieve
a sufficient margin of safety, it is necessary to resect the hepatic duct of the
unaffected lobe of the liver6. The bilioenteric continuity is then reconstituted by a
hepaticojejunal anastomosis using a Roux-en-Y-loop of jejunum. The caudate lobe
drains by small bile duct branches into the right as well as the left hepatic duct. As
hilar cancer spreads predominantly by continuity, the routine removal of the
caudate lobe has been suggested in all type III cancers in order to achieve sufficient
safety margins7. However, caudate lobe excision has so far not been accepted as a
routine procedure6. Using this aggressive therapeutic approach to proximal bile
duct cancer, median and mean survival times of 25 and 29 months are reported,
respectively with reasonable morbidity and mortality rates6.
If the tumor invades both main hepatic ducts up to the 2nd order bile duct
branches, no form of hepatic resection can achieve adequate safety margins and.
hemihepatectomy is not indicated, as it would mean an unnecessary sacrifice of
vital liver tissue in view of the questionable radicality.
Four therapeutic options must be considered for this type of tumor:
1. Liver transplantation8’9.
2. Palliative tumor resection combined with radiotherapy1’11.
3. Palliative decompression by percutaneous external drains or internal stents
which can be placed either by percutaneous transhepatic or endoscopic
access12,13.
4. Surgical bypass by intrahepatic cholangioenteric anastomosis14’5.
5. Radiotherapy by external and/or intraluminal irradiation16-19.
We report on our experience with the second treatment modality in patients with
Bismuth type IV proximal bile duct cancer.
Patients
Between August 1983 and June 1988 a total of 12 patients with proximal bile duct
tumors involving both main hepatic ducts, Bismuth type IV (Figure 6a), were
operated in the Department of Surgery, University of Munich. Five patients were
men and 7 women. Ages ranged from 55 to 82 years and averaged 67 years (Table
1). The complete diagnostic work-up included computerized axial tomography,
abdominal ultrasonography, digital subtraction angiography and endoscopic or
percutaneous cholangiography with or without preoperative drainage in all
patients.
Operative Technique
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digital subtraction angiography. No evidence of systemic spread was found preo-
peratively. All patients had resection of gross tumor involvement of the ma.n
hepatic ducts up to the level of the second order confluence. Our technique of
tumor resection is based on the technique described by Cameron et al. 198211. We
also transsected the common bile duct at an early stage in the operation to facilitate
clearance of the tumor from the portal vein. In three of these patients, tumor
invasion of the gall bladder necessitated an additional partial resection of segment
IV of the liver. Biliary drainage was ensured by constructing a bilioenteric
anastomosis as described by R. Smith
2 (Figure 2). After resection of the tumor by
an atypical resection of the hilar segments, 3-6 stumps of intrahepatic 2nd order
bile ducts are exposed in the depth of the hepatic hilum. The segmental duct of
segment V is cannulated via the common duct of segment V and VIII (depending
on the depth of the resection) and a silicon tube (21 Charriere Robinson tube,
Boehringer Ingelheim, FRG) is passed transhepatically to the antero-lateral sur-
face of the liver. On the left side the segmental duct of segment III is cannulated via
Figure 2 Schematic drawing of the sutureless bilioenteric anastomosis Rodney Smith 17.240 D. K. WILKER ET AL.
the common duct of segment II and III and a second silicon tube is advanced
transhepatically. The right tube is advanced through the abdominal wall in the right
hypochondrium, whereas the left tube is placed in the left epigastric region.
Kinking has to be avoided at this stage. A Roux-en-Y loop of 30 cm in length is
constructed and brought up via a retrocolic route to the hilum of the liver. On two
neighbouring spots laying antimesenterically, a disc of seromuscular layer, dia-
meter 1.5 to 2 cm is excised. The protruding mucosa is incised and a purse string
suture is applied. The tubes are now passed into the bowel lumen. The tubes are
secured by tying the purse string sutures. Two additional sutures (all suture
material used is absorbable) are passed through the full thickness of the bowel wall
adjacent to the mucosa and passed through the tube itself. They serve to fix the
bowel to the tubes, when traction is applied (Figure 3). The jejunal loop is then
brought up to the hepatic hilum by pulling on the tubes with slight tension and the
tubes are fixed to the abdominal wall. Thus a sutureless bilioenteric anastomosis is
created. The tubes are removed after 6 to 12 weeks (Figures 6a, 6b). Five patients
received postoperative combined radiotherapy starting at three weeks postoperati-
vely. A suitable length of 192-Iridium-wire, assessed from the cholangiographic
appearance was placed within an angiographic guide wire. Under radiographic
control the guide wire was positioned via the external limbs of the percutaneous
transhepatic tubes until the segment of the active irridium lay within the main
tumor bed (Figure 4). The radiation, calculated at 0.5 cm from the wire, was then
Figure 3 Positioning of transhepatic tubes into the jejunal lumen.PALLIATION OF PROXIMAL BILE DUCT CANCER 241
Figure 4 Positioning of the Iridium-wire via the external limb of the transhepatic tubes into the tumor
bed for intraluminal radiotherapy.242 D. K. WILKER ETAL.
administered at a dose of 10 gray on three occasions at weekly intervals.
Additionally external beam irradiation using a standard three field technique was
given to the patients, so as to deliver 36 Gy. A total dose of 66 Gy was delivered.
Radiation therapy was discontinued 7-8 weeks postoperatively.
RESULTS
Preoperative risk assessment revealed severe operative risk factors in 9 patients, 5
patients showed more than one risk factor. In all 9 patients severe cardiovascular
disease was present. Additionally two patients exhibited severe diabetes mellitus
and one patient showed concommitant pulmonary or renal disease, respectively.
Thus, more than two thirds of our patients were assessed as high risk patients,
classified as class III according to the American Society of Anesthesiologists’
Physical status classification21. In 6 patients the tumor was technically resectable
and there was no evidence of gross residual tumor postoperatively.
Pathohistological evaluation of the resected specimen confirmed microscopic resi-
dual tumor. In the remaining 6 patients gross residual tumor was evident after
resection. These patients did not survive many months (Table 1). Three patients
showed invasion of the gallbladder requiring resection of segment IV of the liver.
In four patients nodal involvement of metastatic spread was evident at the time of
surgery (Table 1). One 82 year old patient died of cardiac failure on the 7th
postoperative day, otherwise there was no postoperative mortality. One patient
developed an abscess of the liver, requiring percutaneous drainage and antibiotic
therapy. In another patient a bile leak between liver surface and abdominal wall
developed, which was drained and sealed spontaneously. In 3 early patients the
tubes dislocated 2 weeks postoperatively without any clinical consequences. Two
patients developed mild cholangitis. They were successfully managed with antibio-
tics. In two patients abdominal wound infections were evident. Thus, no life-
threatening complications were observed.
Following discharge a continuous decline of serum bilirubin to normal levels was
observed in 7 patients. In two patients with gross residual tumor a postoperative
increase of serum bilirubin was observed. Both patients died of disease 2 and 3
months later, respectively. Two patients with gross residual tumor exhibited a
delayed decrease in serum bilirubin, they survived 5 and 7 months, respectively
(Figure 5). Ten patients died of disease in the observation period (Table 1). The
mean survival time at this writing is 11.5 months, the median survival time is 10
months. In the one surviving patient serum bilirubin is still in normal range. Five of
11 patients survived for more than 12 months. The median symptomfree interval
was 9 months. In this time the patients were able to lead a normal life without
external tubes.
DISCUSSION
Adequate treatment of Bismuth type IV proximal bile duct cancer requires subtle
preoperative staging by ERC, Angiography and CAT-scan4’5. If distant metastases
are evident, the survival time will be short. Therefore only a palliative procedure








for proximal bile duct cancer
preoperative postoperative
Figure 5 Total serum bilirubin level in 11 patients after palliative tumor resection and sutureless
bilioenteric anastomosis.
and pruritus is justified. In this case (systemic disease or local irresectability)
endoscopic or radiologic palliative procedures are indicated12’13’14. These pro-
cedures include biliary prostheses, which can be introduced by endoscopic
13 or by
percutaneous transhepatic means12’4. The endoscopic route seems to be associated
with few complications,
TM but in most instances the percutaneous route is chosen.244 D.K. WILKER ETAL.
External percutaneous transhepatic drainage (EPTD) is indicated if transtubation
of the tumor by a biliary prosthesis is not possible because of the firmness of the
tumor12’13’14. These methods are associated with limitations of quality of life and a
high complication rate of up to 30% (cholangitis, catheter obstruction);6’12’3’8’19
therefore they should be applied only to patients who pose severe symptoms of
obstructive jaundice like pruritus or cholangitis and who have a very limited
prognosis.
In case of locally advanced tumors surgical drainage procedures are reported in
the literature. Palliation is achieved by creating a surgical bypass through intrahe-
patic cholangioenteric anastomosis with the tumor in the porta hepatis left
behind2’3’15. These operations include the Longmire procedure and intrahepatic
cholangioenteric anastomosis, in which the intrahepatic bile duct of segment III or
V, respectively is joined to a Roux-en-Y-loop of jejunum after partial resection of
the respective segment. A mortality rate of up to 10% is reported; therefore these
procedures should be only performed in patients with acceptable operative risk. On
the other hand, their palliative effect is only limited6’. After adequate selection of
patients the experience of some authors has been reported as excellent3’4.
The only curative approach to hilar cancer with involvement of both main
hepatic ducts is liver transplantation. Only patients, who
1. have no evidence of distant metastases
2. or regional lymphnodes
3. are under 60 years of age
4. have no severe concommitant disease
should be selected for this procedure6.
These selection criteria almost always lead to exclusion of patients with bile duct
cancer, since the vast majority of patients presenting with this disease are over 60
years of age22. Therefore the appropriate surgical management of advanced
proximal bile duct tumors is still not firmly established. None of our patients would
have been a candidate for liver transplantation.
Our therapeutic concept of palliative tumor resection and additive combined
radiotherapy is based on the idea that a radical resection of tumors which involve
both main hepatic ducts is not possible for anatomical reasons. Residual disease is
10 16 23 treated by radiotherapy This concept has been already described by Langer et
al. and Cameron et al.’, but mostly for tumors which involve the hepatic
confluence and do not invade the level of the second order bile ducts. In Cameron’s
series a mean survival time of 18 months was reported which seems to be more
favorable than our experience with a mean survival time of 11.5 months. This
difference could be explained by the fact, that 37% of patients in Cameron’s series
were resected with a curative intent, whereas in our series the localisation of the
tumor was so unfavorable that only a palliative tumor resection could be carried
out. Involvement of the resection margins by bile duct cancer is supposed to have a
negative effect on survival, but this issue has been questioned in a recent study6.
In our experience, the palliation is especially favourable in patients where no
gross residual disease is evident (R-l-resection). Patients with gross residual tumorPALLIATION OF PROXIMAL BILE DUCT CANCER 245
had a short survival time and only limited benefit from the procedure. In order to
achieve a R-l-stage of resection, the bile ducts have to be transected at the level of
the 2nd order branches. Reconstruction of bilio-enteric continuity at this height
meets technical problems. Basically there are two alternatives: A sutured cholan-
gioenteric anastomosis1’11 or a sutureless cholangioenteric anastomosis in the
technique of Rodney Smith2.
For technical reasons the first alternative requires resection of segments IV and
V of the liver. In our view this means an unnecessary extension of the operation,
especially if one considers the palliative character of the operation.
The sutureless cholangioenteric anastomosis is easy and safe to perform.
Originally it was described for benign strictures of the proximal bile duct2. Our
experience shows that it can be safely employed in malignant strictures, too. This
type of cholangioenteric anastomosis is strongly opposed by some authors, who
argue that only particular segments of the liver allow adequate biliary drainage22. In
our experience the formerly undrained 2nd order bile duct branches gain access to
the Roux-en-Y-loop (Figure 6b), as assessed by postoperative cholangiography via
the tubes and regular ultrasound examinations. Moreover, it is easy to perform.
The cholostasis will be effectively controlled in most cases after palliative
resection and cholangioenteric anastomosis (Figure 5). Besides its technical
simplicity, this procedure offers the advantage of an easy access for intraluminal
radiation therapy via the large percutaneous transhepatic tubes (Figure 3). In the
case of a sutured anastomosis, most often several thin biliary stents are introduced,
which do not provide a lumen wide enough for introduction of the iridium wire.
Bile duct cancer can be considered as a radiosensitive tumor16’18’19’23. In patients,
treated by palliative drainage procedures with the tumors left in place, radiation
therapy was able to induce prolongation of the average survival time16. In addition,
regressive changes have been observed in irridiated tumors25. Intraluminal radioth-
erapy with 192-Iridium led to prolongation of survival as well; nearly 50% of
patients survived for more than 12 months19’24. This figure is surprisingly high in
view of our results, but the fact has to be considered that in these series bile duct
tumors of all locations were included, whereas our series was comprised of patients
with a particularly dismal prognosis due to advanced tumors involving both lobes of
the liver. So far, the question whether palliative resection of the tumor or
radiotherapy alone will lead to better palliation, cannot be answered. A prospec-
tive controlled clinical randomized trial is necessary for further evaluation.
A major set back to palliative biliary decompression combined with internal
radiation therapy is the substantial mortality and morbidity, especially the high
incidence of cholangitis, reaching a rate of up to 40% 19. However, in a recent study,
a mortality of zero and an incidence of cholangitis of 14% were described, with a
median survival of 10.5 monthsTM.
Our approach to treatment of proximal bile duct cancer combines the advantages
of intraluminal and percutaneous radiation therapy with improvement of quality of
life, which results from palliative tumor resection. Due to our limited number of
patients so far we cannot prove that additive radiotherapy indeed leads to
prolongation of survival. The comparison of our approach to liver transplantation
shows that our patients presented with a more unfavorable prognosis due to
advanced age and concommitant risk factors. Nonetheless, the average survival
time of our series was 11.5 months (median 10 months) as compared to a recent246 D. K. WILKER ETAL.
Figure 6a Pat. S.W. female, 62 years old. Preoperative percutaneous transhepatic cholangiography
showing a proximal bile duct cancer with invasion of both main hepatic ducts and extension to the 2nd
order bile ducts.PALLIATION OF PROXIMAL BILE DUCT CANCER 247
Figure 6b Pat. S.W. female, 62 years old. Cholangiography 4 weeks after palliative tumor resection
and bilateral sutureless bilioenteric anastomosis. The intrahepatic bile ducts are draining into the
Roux-en-Y-loop.248 D.K. WILKER ETAL.
series of 16 patients after liver transplantation (average survival time 9.5 months,
median 16 months)8. Moreover, 6-8 weeks postoperatively the treatment is
terminated, the patient is devoid of tubes and a complex follow-up as after liver
transplantation is not necessary.
Our therapeutic approach leads to effective palliation with acceptable morbidity
and mortality if one succeeds in resecting the tumor without leaving gross residual
tumor behind.
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